[2]
Zlotorynski E. The innate function of circular RNAs. Nat Rev Mol Cell Biol 2019; 7: 387.
[3]
Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 2019; 11: 675-91.
[4]
Flemming A. The enigma of circular RNA. Nat Rev Immunol 2019; 6: 351.
[5]
Sun J, Li B, Shu C, Ma Q, Wang J. Functions and clinical significance of circular RNAs in glioma. Mol Cancer 2020; 1: 34.
[29]
Szabo L, Morey R, Palpant NJ, Wang PL. Erratum to: Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development. Genome Biol 2016; 17(1): 263.
[30]
Gokool A, Anwar F, Voineagu I. The landscape of circular RNA expression in the human brain. Biol Psychiatry 2019. Biol Psychiatry 2020; 87(3): 294-304.
[33]
Starling S. Alzheimer disease: Blood-derived Aβ induces AD pathology. Nat Rev Neurol 2018; 14(1): 2.
[34]
Lonskaya I, Shekoyan AR, Hebron ML, et al. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer’s disease. J Alzheimers Dis 2013; 1: 231-47.
[36]
Lukiw JW. Circular RNA (circRNA) in Alzheimer’s disease (AD). Front Genet 2013; 4: 307.
[38]
Julia SD, Sara A, Marcel S, et al. MicroRNA-138 is a potential regulator of memory performance in humans. Front Hum Neurosci 2014; 8: 501.
[39]
Zimmerman AJ, Hafez AK, Amoah SK, et al. A psychiatric disease-related circular RNA controls synaptic gene expression and cognition. Mol Psychiatry 2020; 25(11): 2712-27.
[42]
Ma N, Pan J, Ye X, Yu B, Zhang W, Wan J. Whole-transcriptome analysis of APP/PS1 mouse brain and identification of circRNA-miRNA-mRNA networks to investigate AD pathogenesis. Mol Ther Nucleic Acids 2019; 18: 1049-62.
[46]
Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP.
[48]
Cozzolino M, Ferri A, Valle C, Carrì MT. Mitochondria and ALS: Implications from novel genes and pathways. Mol Cell Neurosci 2013; 55: 44-9.
[51]
Roos RA. Huntington’s disease: A clinical review. Eur J Neurol 2018; 25(1): 24-34.
[53]
Xu K, Schadt EE, Pollard KS, Roussos P, Dudley JT. Genomic and network patterns of schizophrenia genetic variation in human evolutionary accelerated regions. Mol Biol Evol 2015; 5: 1148-60.
[54]
Hwang J-Y, Zukin RS. REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol 2018; 48: 193-200.
[57]
Francelle L, Galvan L, Gaillard MC. The striatal long non-coding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in-vivo. Neurobiol Aging 2015; 3: 1601-7.
[74]
Khodor YL, Menet JS, Tolan M, Rosbash M. Cotranscriptional splicing efficiency differs dramatically between Drosophila and mouse. RNA 2012; 12: 2174-86.
[75]
Cheng L, Zhao W, Hill AF. Exosomes and their role in the intercellular trafficking of normal and disease associated prion proteins. Mol Aspects Med 2018; 60: 62-8.